### ü´† Arrhythmias: Genetic Long QT Syndrome Evaluation

#### ‚úÖ True Statements
1. **Genetic long QT syndrome** is one of the most common inherited arrhythmias and can present as **sudden cardiac death (SCD)** due to **torsades de pointes**.
2. **Genetic long QT syndrome** affects up to **1 in 1000 persons**.
3. A **prolonged QTc interval alone** is insufficient to diagnose **genetic long QT syndrome**, as QT intervals can fluctuate and may be prolonged due to **medications**, **electrolyte disturbances**, or **structural heart disease**.
4. **Normal QTc values** are **<440 ms in men** and **<460 ms in women**, but there is some variation across individuals.
5. **Medications** that may cause secondary QT prolongation include **antiarrhythmic agents**, **antibiotics**, and **neuroleptics**.
6. **Electrolyte abnormalities** such as **hypokalemia**, **hypomagnesemia**, and **hypocalcemia** can cause QT prolongation.
7. Patients suspected of having **genetic long QT syndrome** should be referred to a **cardiac electrophysiologist** for further evaluation and possible **genetic testing**.
8. **Brugada syndrome** is associated with arrhythmic events including **sudden cardiac death**, and its ECG findings include **ST-segment coving** in leads **V1 through V3**, with or without **right bundle branch block**.
9. **Hypertrophic cardiomyopathy (HCM)** may present as **sudden cardiac death** in young individuals and has characteristic **electrocardiographic findings** such as **increased QRS voltage** and **extensive repolarization abnormalities**.
10. **Vasovagal syncope** typically presents with a **prodrome** of **nausea**, **light-headedness**, or **abdominal discomfort**, and symptoms often persist after the episode.
11. **Vasovagal syncope** is less likely when syncope occurs with **exercise**, has **no prodrome**, and is accompanied by a **suspicious family history**, which instead raises concern for **arrhythmic syncope**.

#### üí¨ Extra
1. Torsades de pointes is a form of polymorphic ventricular tachycardia that may cause sudden cardiac death in genetically susceptible individuals with long QT syndrome.
2. A high prevalence underscores the importance of early detection, especially in young patients with unexplained syncope or family history of sudden death.
3. Diagnostic evaluation of QT interval prolongation requires ruling out reversible causes such as drugs and metabolic disturbances.
4. These cutoff values help screen for abnormal QT intervals, but individual variation necessitates clinical judgment and family history consideration.
5. QT-prolonging medications should be reviewed and discontinued if clinically safe when evaluating unexplained syncope.
6. Hypokalemia and other electrolyte disturbances are among the most common reversible causes of prolonged QT.
7. Evaluation by an electrophysiologist may include Holter monitoring, exercise testing, or provocation testing in addition to genetic analysis.
8. Brugada syndrome often goes unrecognized unless the characteristic ECG pattern is identified or unmasked during febrile illness or with certain medications.
   <br>
   <figure>
     <img src="Brugada syndrome.jpg" alt="ECG showing Brugada syndrome">
     <figcaption>
       ECG in Brugada syndrome demonstrates ST-segment coving in leads V1‚ÄìV3 with or without right bundle branch block. Source: Educational Objective Image, CVMCQ24111.
     </figcaption>
   </figure>
9. Echocardiography should also be performed in young patients with syncope to evaluate for structural heart disease such as hypertrophic cardiomyopathy.
   <br>
   <figure>
     <img src="Hypertrophic cardiomyopathy (HCM).jpg" alt="ECG showing HCM findings">
     <figcaption>
       ECG in hypertrophic cardiomyopathy shows increased QRS voltage and repolarization abnormalities. Source: Educational Objective Image, CVMCQ24111.
     </figcaption>
   </figure>
10. Symptoms such as nausea or light-headedness suggest a benign vasovagal etiology, especially when events occur with emotional stress or orthostatic triggers.
11. Syncope during exertion without warning is highly concerning for arrhythmogenic causes, especially in the context of a family history of sudden death.

#### üî∑ Tags
#Cardiology #EmergentCare #PatientUnder25 #GeneticArrhythmias #LongQTSyndrome #BrugadaSyndrome #HypertrophicCardiomyopathy #Syncope

#### üìô Reference
Krahn AD, Laksman Z, Sy RW, et al. Congenital long QT syndrome. *JACC Clin Electrophysiol*. 2022;8:687-706. PMID: 35589186 doi:10.1016/j.jacep.2022.02.017

#### üÜî Question ID
CVMCQ24111

#### üïí Last Updated
January 2025

---

#### üìñ Related Text
Cardiovascular Medicine ‚Äî Arrhythmias: Inherited Syndromes Characterized by Sudden Cardiac Death

---

### üìò Related Text Derivations

#### ‚úÖ True Statements
1. Patients younger than **40 years** with **unexplained cardiac arrest**, **near drowning**, **syncope during exercise**, or **recurrent high-risk syncope** without **ischemic or structural heart disease** should be evaluated for **inherited arrhythmia or cardiomyopathy syndromes**.
2. **Unexplained sudden or premature death** in a **first-degree relative younger than 40 years** should prompt referral to a cardiovascular specialist for evaluation of **inherited arrhythmia syndromes**.
3. Diagnosis of **inherited arrhythmia syndromes** can be complex due to **variable penetrance and expressivity**, and may require **genetic counseling** and **testing**.
4. **Genetic long QT syndrome** affects approximately **1 in 1000 to 1 in 5000 persons**.
5. A **QTc >440 ms in men** or **>460 ms in women** is suggestive but **not diagnostic** of **genetic long QT syndrome**.
6. **Causes of QT prolongation** include **medications**, **structural heart disease**, and **electrolyte abnormalities**, which are typically **acquired** rather than genetic.
7. Patients with suspected **long QT syndrome** should be referred to a **cardiac electrophysiologist**, and first-line treatment includes **Œ≤-blockers**, **avoidance of QT-prolonging medications**, and **ICD** placement or **surgical sympathectomy** for high-risk patients.
8. **Brugada syndrome** is characterized by **ST-segment coving** in **leads V1‚ÄìV3**, often with **right bundle branch block**, and is associated with **ventricular tachyarrhythmias** and **sudden cardiac death**.
9. In **Brugada syndrome**, **ECG abnormalities** may be **intermittent**, and arrhythmias are more common during **sleep**; abnormalities can be provoked with **fever** or **sodium channel blockers**.
10. **Hypertrophic cardiomyopathy** and **arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D)** can cause **sudden cardiac death** in young individuals.
11. **ARVC/D** typically presents between **puberty and young adulthood** with **frequent ventricular ectopy**, **monomorphic ventricular tachycardia**, or **heart failure** in advanced stages.
12. Diagnosis of **ARVC/D** includes a combination of **ECG findings**, **family history**, **arrhythmia documentation**, and **structural imaging**.
13. Treatment for **ARVC/D** includes **exercise restriction**, **Œ≤-blockers**, and **ICD placement** in high-risk patients, with **sotalol**, **amiodarone**, or **catheter ablation** as needed for recurrent **ventricular tachycardia**.


#### üí¨ Extra
1. These presentations may be the first sign of an inherited arrhythmia syndrome in otherwise healthy young individuals and warrant evaluation when no structural or ischemic disease is found.
2. Family history should include unexplained drownings, motor vehicle accidents, or seizures, as these may reflect undiagnosed arrhythmic events.
3. Even in genotype-positive individuals without overt ECG abnormalities, penetrance and expressivity vary, necessitating genetic counseling.
4. The diagnosis of long QT syndrome is difficult due to fluctuating QT interval durations, and ECG is supported by genetic and clinical correlation.
6. QT prolongation is commonly acquired due to drug exposure (e.g., antiarrhythmics, antipsychotics) or electrolyte abnormalities such as hypokalemia or hypomagnesemia.
7. Œ≤-Blockers are first-line therapy; ICDs or sympathectomy are considered in those with syncope or ventricular arrhythmia despite medical treatment.
8. ST-segment morphology in Brugada syndrome may be unmasked with pharmacologic provocation or during febrile illness.
10. These structural cardiomyopathies are the most common causes of sudden death in athletes and may be silent without ECG or imaging evaluation.


#### üî∑ Tags
#InheritedArrhythmias #SuddenCardiacDeath #LongQTSyndrome #BrugadaSyndrome #HypertrophicCardiomyopathy #ARVC #GeneticTesting #Cardiology

#### üóæ Supplemental Tables

<!-- Inherited Syndromes Characterized by Sudden Cardiac Death -->
<table>
  <caption><strong>Inherited Syndromes Characterized by Sudden Cardiac Death</strong></caption>
  <thead>
    <tr>
      <th>Disorder</th>
      <th>Presenting Symptoms and Characteristic Findings</th>
      <th>Potential Treatments<sup>a</sup></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Long QT syndrome</td>
      <td>Syncope during sleep, auditory triggers, and/or during exercise (depending on subtype); QTc usually >460 ms; torsades de pointes</td>
      <td>Œ≤-Blockers, avoidance of QT-prolonging drugs; selected patients: ICD, sympathectomy, exercise restriction</td>
    </tr>
    <tr>
      <td>Brugada syndrome</td>
      <td>Syncope during sleep, VF, coved ST-segment elevation in early precordial leads (V<sub>1</sub> through V<sub>3</sub>)</td>
      <td>ICD, avoidance or management of triggers (drugs, fever), catheter ablation</td>
    </tr>
    <tr>
      <td>Catecholaminergic polymorphic VT</td>
      <td>Syncope, polymorphic or bidirectional VT during exercise or emotional distress</td>
      <td>Œ≤-Blockers, verapamil, flecainide, ICD, exercise abstinence (uniform)</td>
    </tr>
    <tr>
      <td>Arrhythmogenic right ventricular cardiomyopathy/dysplasia</td>
      <td>Syncope, palpitations, T-wave inversions in leads V<sub>1</sub> through at least V<sub>3</sub>, monomorphic VT, frequent PVCs, and abnormal right ventricular size and function on echocardiography or CMR imaging</td>
      <td>ICD, Œ≤-blockers, antiarrhythmic medications, catheter ablation, exercise abstinence (uniform)</td>
    </tr>
    <tr>
      <td>Hypertrophic cardiomyopathy</td>
      <td>Syncope, VF during exercise, increased QRS voltage with or without repolarization abnormalities on ECG</td>
      <td>ICD, Œ≤-blockers, disopyramide, catheter ablation, surgical myectomy</td>
    </tr>
  </tbody>
</table>

<p><em>CMR = cardiac magnetic resonance; ICD = implantable cardioverter-defibrillator; PVC = premature ventricular contraction; QTc = corrected QT interval; VF = ventricular fibrillation; VT = ventricular tachycardia.</em><br>
<sup>a</sup>Treatment recommendations for ICD placement in inherited arrhythmia syndromes are guided by risk stratification with criteria that are often disease specific. In addition, antiarrhythmic drugs are often required for recurrent ventricular arrhythmias.</p>

#### üñºÔ∏è Supplemental Figures

<figure>
  <img src="ECG Demonstrating Significant Prolongation of the QT Interval.jpg" alt="QT interval prolongation ECG">
  <figcaption>
    ECG showing significant QT interval prolongation with abnormal morphology, especially in the early precordial leads. When heart rate is below 60/min, the absolute QT interval is used rather than the corrected QT (QTc).
  </figcaption>
</figure>

<figure>
  <img src="ECG Demonstrating a Type 1 Brugada Pattern.jpg" alt="Brugada ECG pattern">
  <figcaption>
    ECG demonstrating a type 1 Brugada pattern with ‚â•2 mm J-point elevation, ST-segment coving (concave or downsloping), and T-wave inversions in leads V1‚ÄìV3.
  </figcaption>
</figure>